SPECT/CT and tumour imaging

被引:6
|
作者
Abikhzer, Gad [1 ]
Keidar, Zohar [1 ,2 ]
机构
[1] Rambam Hlth Care Campus, Dept Nucl Med, IL-31096 Haifa, Israel
[2] Technion Israel Inst Technol, Ruth & Bruce Rappaport Fac Med, Haifa, Israel
关键词
SPECT/CT; Hybrid imaging; Tumour; SOMATOSTATIN RECEPTOR SCINTIGRAPHY; DIFFERENTIATED THYROID-CARCINOMA; INTRAOPERATIVE GAMMA-PROBE; SQUAMOUS-CELL CARCINOMA; COMPUTED TOMOGRAPHY/COMPUTED TOMOGRAPHY; SENTINEL NODE IDENTIFICATION; CONCOMITANT NODULAR GOITER; NEUROENDOCRINE TUMORS; BREAST-CANCER; PRIMARY HYPERPARATHYROIDISM;
D O I
10.1007/s00259-013-2534-4
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Scintigraphic techniques are sensitive imaging modalities in the diagnosis and follow-up of cancer patients providing the functional and metabolic activity characteristics of the tumour. Hybrid SPECT/CT improves the diagnostic accuracy of these well-established imaging techniques by precise anatomical localization and characterization of morphological findings, differentiation between foci of physiological and pathological tracer uptake, resulting in a significant impact on patient management and more definitive interpretations. The use of SPECT/CT has been studied in a variety of applications in tumour imaging which are reviewed in this article. By combining functional and anatomical information in a single imaging session, SPECT/CT has become a one-stop cancer imaging modality.
引用
收藏
页码:S67 / S80
页数:14
相关论文
共 50 条
  • [1] SPECT/CT and tumour imaging
    Gad Abikhzer
    Zohar Keidar
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 67 - 80
  • [2] Multimodality imaging of a tumour model in vivo with SPECT/CT and bioluminescence imaging
    Pool, S. E.
    Mueller, C.
    Koning, G. A.
    Breeman, W. A. P.
    Eggermont, A. M. M.
    van Eijck, C. H. J.
    Krenning, E. P.
    ten Hagen, T. L. M.
    de Jong, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 : S200 - S200
  • [3] 99mTc-labelled nanosystem as tumour imaging agent for SPECT and SPECT/CT modalities
    Polyak, Andras
    Hajdu, Istvan
    Bodnar, Magdolna
    Trencsenyi, Gyoergy
    Poestenyi, Zita
    Haasz, Veronika
    Janoki, Gergely
    Janoki, Gyozo A.
    Balogh, Lajos
    Borbely, Janos
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2013, 449 (1-2) : 10 - 17
  • [4] Molecular imaging agents for SPECT (and SPECT/CT)
    Gnanasegaran, Gopinath
    Ballinger, James R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S26 - S35
  • [5] Technological Advances in SPECT and SPECT/CT Imaging
    Bouchareb, Yassine
    AlSaadi, Afrah
    Zabah, Jawa
    Jain, Anjali
    Al-Jabri, Aziza
    Phiri, Peter
    Shi, Jian Qing
    Delanerolle, Gayathri
    Sirasanagandla, Srinivasa Rao
    DIAGNOSTICS, 2024, 14 (13)
  • [6] Molecular imaging agents for SPECT (and SPECT/CT)
    Gopinath Gnanasegaran
    James R. Ballinger
    European Journal of Nuclear Medicine and Molecular Imaging, 2014, 41 : 26 - 35
  • [7] SPECT/CT hybrid imaging; with which CT?
    Bach-Gansmo, Tore
    Schwarzlmuller, Thomas
    Joraholmen, Vivi
    Salbu, Jan
    Biermann, Martin
    Naum, Alexandru
    Kleven-Madsen, Nina
    CONTRAST MEDIA & MOLECULAR IMAGING, 2010, 5 (04) : 208 - 212
  • [8] Hybrid SPECT/CT: a new era for SPECT imaging?
    Schillaci, O
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2005, 32 (05) : 521 - 524
  • [9] Hybrid SPECT/CT: a new era for SPECT imaging?
    Orazio Schillaci
    European Journal of Nuclear Medicine and Molecular Imaging, 2005, 32 : 521 - 524
  • [10] The application of using SPECT imaging to position the range of CT acquisition in SPECT/CT
    Wang, Yuankai
    Liu, Zhuang
    JOURNAL OF NUCLEAR MEDICINE, 2014, 55